Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last kr566.00 SEK
Change Today +7.50 / 1.34%
Volume 89.5K
AZN On Other Exchanges
Symbol
Exchange
New York
Xetra
Stockholm
OTC US
Mexico
Berlin
As of 7:15 AM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for astrazeneca plc (AZN)

Currency in
Millions of US Dollars
As of:Dec 31
2011
Restated
Dec 31
2012
Restated
Dec 31
2013
Dec 31
2014
4 Year
Trend
NET INCOME9,917.06,240.02,556.01,233.0
Depreciation & Amortization1,086.01,023.0906.0776.0
Amortization of Goodwill and Intangible Assets771.01,134.01,591.02,201.0
DEPRECIATION & AMORTIZATION, TOTAL1,857.02,157.02,497.02,977.0
Amortization of Deferred Charges140.0162.0188.0183.0
(Gain) Loss from Sale of Asset-1,483.0------
Asset Writedown & Restructuring Costs553.0199.01,898.0122.0
Other Operating Activities-2,266.0-1,104.095.029.0
(Income) Loss on Equity Investments------6.0
Change in Accounts Receivable-1,108.0755.0-383.0311.0
Change in Inventories-256.0-150.0135.0108.0
Change in Accounts Payable467.0-1,311.0414.02,089.0
CASH FROM OPERATIONS7,821.06,948.07,400.07,058.0
Capital Expenditure-839.0-672.0-742.0-1,012.0
Sale of Property, Plant, and Equipment102.0199.069.0158.0
Cash Acquisitions-16.0-1,207.0-1,168.0-4,471.0
Divestitures1,772.0--42.0--
Sale (Purchase) of Intangible Assets-458.0-3,947.0-1,281.0-1,740.0
Investments in Marketable & Equity Securities-2,754.03,616.077.0-107.0
CASH FROM INVESTING-2,022.0-1,859.0-2,889.0-7,032.0
Short-Term Debt Issued46.0687.0--520.0
Long-Term Debt Issued--1,980.0--919.0
TOTAL DEBT ISSUED46.02,667.0--1,439.0
Short Term Debt Repaid-----5.0--
Long Term Debt Repaid---1,767.0-27.0-786.0
TOTAL DEBT REPAID---1,767.0-32.0-786.0
Issuance of Common Stock409.0429.0482.0279.0
Repurchase of Common Stock-6,015.0-2,635.0----
Common Dividends Paid-3,764.0-3,665.0-3,461.0-3,521.0
TOTAL DIVIDEND PAID-3,764.0-3,665.0-3,461.0-3,521.0
Other Financing Activities3.048.0-36.0-116.0
CASH FROM FINANCING-9,321.0-4,923.0-3,047.0-2,705.0
Foreign Exchange Rate Adjustments-25.0-4.0-65.0-152.0
NET CHANGE IN CASH-3,547.0162.01,399.0-2,831.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AZN:SS kr566.00 SEK +7.50

AZN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $50.94 USD +0.25
BASF SE €77.21 EUR -0.52
Biogen Inc $319.93 USD +10.50
Eli Lilly & Co $85.68 USD +1.53
Valeant Pharmaceuticals International Inc C$333.91 CAD -3.58
View Industry Companies
 

Industry Analysis

AZN

Industry Average

Valuation AZN Industry Range
Price/Earnings 64.5x
Price/Sales 3.2x
Price/Book 4.9x
Price/Cash Flow 64.4x
TEV/Sales 3.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ASTRAZENECA PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.